Queen Esther and the flap of a butterfly’s wing

By Rabbi Dr Moshe Freedman, February 21, 2013

In the summer of 1666, the English physicist and mathematician Sir Isaac Newton is said to have pondered the falling of an apple while in the gardens of Woolsthorpe Manor, his family home in Lincolnshire. This apocryphal story describes the seminal moment which prompted him to realise that there must be a force acting on the apple which draws it to the centre of the earth.


A game-changing cancer vaccine?

By Anna Sheinman, February 1, 2013

Results of the first clinical trial for a new cancer vaccine developed by an Israeli company suggest it could “change the paradigm” of cancer treatment, the head researcher has said.

Dr Lior Carmon, CEO of Vaxil, based near Tel Aviv, said that the results of the phase I trial of the vaccine on 15 cancer patients with multiple myeloma, a blood cancer, were very promising.


Italian Jewish Nobel winner dies at 103

By Jennifer Lipman, December 31, 2012

Tributes have been paid to an Italian scientist who won a Nobel Prize in spite of her career being hampered by antisemitism.

Rita Levi-Montalcini, who was 103 when she died on Sunday, received the Nobel Prize in Medicine in 1986, along with her Jewish colleague Stanley Cohen. The pair had made significant progress in the field of nerve growth factor.


Cameron announces first 'tech envoy to Israel'

By Jennifer Lipman, December 11, 2012

The UK Prime Minister has announced the creation of a "tech envoy to Israel" as part of a move to encourage further co-ordination between the two countries in the start-up and technology fields.

Saul Klein, a partner at investment firm Index Ventures, will act as an unpaid ambassador for tech partnership between Britain and Israel and help build links with innovative Israeli companies.


Sesame accelerator opens doors to scientific co-operation

By Jennifer Lipman, November 29, 2012

A science project aiming to advance research in fields as varied as biology, archaeology and medical sciences is bringing together researchers from Israel and its neighbours around the Middle East.


Pollster's winning accuracy on US presidential elections

By Gil Shefler, November 15, 2012

He’s 50 per cent Jewish — and almost 100 per cent accurate when predicting election results.

Nate Silver, the 34-year-old pollster for the New York Times, was the man in the news last week after he called the elections for incumbent Barack Obama with amazing accuracy.


Attractive women submissive and conformist, says survey

By Anna Sheinman, November 7, 2012

Good-looking women are more likely to be submissive and conformist, a Hebrew University study has found.

The research, done in conjunction with the Open University, hypothesised that women are judged by what they look like. That means that women who are judged to be attractive should theoretically also be perceived as having socially desirable personality traits.


It's not a washing machine — it’s Israel’s attempt to land on the moon

By Marcus Dysch, November 1, 2012

A team of Israeli scientists hope to boldly go where no countryman has gone before — by landing an unmanned spacecraft on the moon.

The SpaceIL project’s mission is to make Israel only the third country ever to complete a successful lunar landing.


'Drugs Live' scientist hails rare opportunity

By Jennifer Lipman, September 27, 2012

A scientist involved with a television programme featuring public figures taking ecstasy has praised it for offering an "unusual opportunity" for studying the aftereffects of the drug.

Dr Jonathan Roiser, from UCL's Institute of Cognitive Neuroscience, is set to appear in the second installment of Channel 4's "Drugs Live: the Ecstasy Trial" programme.


Israel tests out the ‘brain pacemaker’

By Ben Hartman, September 20, 2012

The Hadassah medical centre is currently testing for use in Israel a procedure they say could offer breakthroughs in treating a litany of disorders, from Parkinson’s disease to depression.

Deep Brain Stimulation (DBS) uses a so-called “brain pacemaker” to send electric pulses into the brain of the patient in a very localised manner.